PDF(Sci-hub)
Abstract：
BACKGROUND: Scarce information is available on the resources to deal with the Sexually Transmitted Infections (STIs), both in the clinic and in the laboratory. The objective is to describe and know the reality of the clinics and laboratories that treat these infections in Spain.
METHODS: Cross-sectional observational study with data collection through a survey aimed at the members of the GEITS Group.
RESULTS: Responses were obtained from 24 centers (response rate 38.1%) belonging to 10Autonomous Communities. Regarding STI consultations, 38% require that the patient present a health card to provide assistance, and 31.8% only provide it by referral from another doctor. The 52.4% perform diagnostic methods in the care center. Regarding laboratories, 18.2% do not offer immediate response diagnostic tests, although 100% have PCR against Neisseria gonorrhoeae and Chlamydia trachomatis, 47.8% against Mycoplasma genitalium and 65% detect lymphogranuloma venereum genotypes. All laboratories continue to perform culture and gonococcal sensitivity techniques, and 20% perform molecular methods for detection of MG antimicrobial resistance.
CONCLUSIONS: There is great variability in the provision of human and material resources both in the clinics and in the laboratories that attend STIs. In a significant number of centers there are limitations for patient access. Although laboratories have molecular biology technologies, not all of them offer immediate response tests. All laboratories detect N.gonorrhoeae infection by PCR and also by culture, which allows sensitivity testing in all centers.
METHODS: Cross-sectional observational study with data collection through a survey aimed at the members of the GEITS Group.
RESULTS: Responses were obtained from 24 centers (response rate 38.1%) belonging to 10Autonomous Communities. Regarding STI consultations, 38% require that the patient present a health card to provide assistance, and 31.8% only provide it by referral from another doctor. The 52.4% perform diagnostic methods in the care center. Regarding laboratories, 18.2% do not offer immediate response diagnostic tests, although 100% have PCR against Neisseria gonorrhoeae and Chlamydia trachomatis, 47.8% against Mycoplasma genitalium and 65% detect lymphogranuloma venereum genotypes. All laboratories continue to perform culture and gonococcal sensitivity techniques, and 20% perform molecular methods for detection of MG antimicrobial resistance.
CONCLUSIONS: There is great variability in the provision of human and material resources both in the clinics and in the laboratories that attend STIs. In a significant number of centers there are limitations for patient access. Although laboratories have molecular biology technologies, not all of them offer immediate response tests. All laboratories detect N.gonorrhoeae infection by PCR and also by culture, which allows sensitivity testing in all centers.
摘要：
背景：在处理性传播感染（STIs）的资源上可以获得稀缺信息，在诊所和实验室。目的是描述和了解西班牙治疗这些感染的诊所和实验室的实际情况。
方法：通过针对GEITS组成员的调查收集数据的横断面观察性研究。
结果：从属于10个自治社区的24个中心获得了响应（响应率38.1％）。关于科技创新磋商，38%的人要求患者出示健康卡以提供帮助，31.8%的人只通过另一位医生的转诊提供。52.4％的人在护理中心执行诊断方法。关于实验室,18.2%的人不提供即时反应诊断测试，尽管100％有针对淋病奈瑟菌和沙眼衣原体的PCR，47.8％针对生殖支原体和65％检测到淋巴肉芽肿性病基因型。所有实验室继续进行培养和淋球菌敏感性技术，20%的人使用分子方法检测MG耐药性。
结论：诊所和参加性传播感染的实验室在提供人力和物力方面存在很大差异。在相当多的中心中,患者进入存在限制。虽然实验室有分子生物学技术，并非所有人都提供即时响应测试。所有实验室通过PCR和培养检测淋病奈瑟菌感染，允许在所有中心进行灵敏度测试。
方法：通过针对GEITS组成员的调查收集数据的横断面观察性研究。
结果：从属于10个自治社区的24个中心获得了响应（响应率38.1％）。关于科技创新磋商，38%的人要求患者出示健康卡以提供帮助，31.8%的人只通过另一位医生的转诊提供。52.4％的人在护理中心执行诊断方法。关于实验室,18.2%的人不提供即时反应诊断测试，尽管100％有针对淋病奈瑟菌和沙眼衣原体的PCR，47.8％针对生殖支原体和65％检测到淋巴肉芽肿性病基因型。所有实验室继续进行培养和淋球菌敏感性技术，20%的人使用分子方法检测MG耐药性。
结论：诊所和参加性传播感染的实验室在提供人力和物力方面存在很大差异。在相当多的中心中,患者进入存在限制。虽然实验室有分子生物学技术，并非所有人都提供即时响应测试。所有实验室通过PCR和培养检测淋病奈瑟菌感染，允许在所有中心进行灵敏度测试。
